Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Peripheral Artery Disease Management, Cerebrovascular and Carotid Artery Diseases, Vascular Procedures and Complications, and Coronary Interventions and Diagnostics.
Five-Year Safety and Effectiveness of Paclitaxel Drug-Coated Balloons Alone or With Provisional Bare Metal Stenting for Real-World Femoropopliteal Lesions: IN.PACT Global Study Subgroup Analysis.
De Novo Atherosclerotic Renal Artery Stenosis Covered Stent Treatment for Resistant Hypertension (ARTISAN) Results
Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The <scp>VIVA REALITY</scp> study
Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
Time for pulmonary embolism alert.
Mortality and Paclitaxel-Coated Devices
Mortality Not Correlated With Paclitaxel Exposure
Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices
One-Year Results of the LIBERTY 360 Study: Evaluation of Acute and Midterm Clinical Outcomes of Peripheral Endovascular Device Interventions.
Final Two-Year Outcomes for the Sentry Bioconvertible Inferior Vena Cava Filter in Patients Requiring Temporary Protection from Pulmonary Embolism
Pedal access: Put the "pedal to the metal" or drive with caution?
One-Year Analysis of the Prospective Multicenter SENTRY Clinical Trial: Safety and Effectiveness of the Novate Sentry Bioconvertible Inferior Vena Cava Filter
Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study
Patient‐level meta‐analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation
Carotid Stent Fractures Are Not Associated With Adverse Events
Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery
Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal
Heparin-bonded, Expanded Polytetrafluoroethylene-lined Stent Graft in the Treatment of Femoropopliteal Artery Disease: 1-Year Results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) Trial